Thursday, September 6, 2018
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable – TechCrunch
Marijuana may still be on shaky legal ground, but the therapeutic benefits of the psychoactive molecules — cannabinoids — inside the plant are solidly established. Unfortunately, cultivation of that plant is resource-intensive and yields only tiny amounts of some useful medicines. CB Therapeutics, a new biotech company launching today at the Disrupt SF Startup Battlefield, aims to change the 
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
-
Following the release of iOS 10.3.2 on May 15, Apple has stopped signing iOS 10.3.1, the previous version of iOS that was available to consu...
No comments:
Post a Comment